Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-blinded, Randomized, Controlled, Comparative Phase III Study Evaluating the Safety and Effectiveness of EVARREST™ Fibrin Sealant Patch as an Adjunct to Hemostasis During Cardiovascular Surgery

NCT02040428 is registered in ClinicalTrials.gov with Ethicon, Inc. as lead sponsor.

NCT NCT02040428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02040428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-blinded, Randomized, Controlled, Comparative Phase III Study Evaluating the Safety and Effectiveness of EVARREST™ Fibrin Sealant Patch as an Adjunct to Hemostasis During Cardiovascular Surgery
Lead sponsor
Ethicon, Inc.
Phase
Phase 3
Overall status
Completed
Start date
January 1, 2014
Completion date
September 1, 2015
Enrollment
156 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease